Daily Archives: November 28, 2021
WHO Update on Omicron + Several Articles on the Subject.
28 Nov, 2021 | 21:38h | UTCUpdate on Omicron – World Health Organization
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern – World Health Organization
See also:
Omicron COVID-19 variant: Africa CDC statement
‘Patience is crucial’: Why we won’t know for weeks how dangerous Omicron is – Science
New Covid variant: Will new measures against Omicron work? – BBC
Vaccine inequity and hesitancy made the Omicron variant more likely, scientists say – CNN
Travel bans aren’t the answer to stopping new COVID variant Omicron – The Conversation
Scientists sharing Omicron data were heroic. Let’s ensure they don’t regret it – The Guardian
The Omicron variant reveals the true global danger of ‘vaccine apartheid’ – The Guardian
We Know Almost Nothing About the Omicron Variant – The Atlantic
Covid: New Omicron variant not a disaster, says Sage scientist – BBC
New Covid variant: Will new measures against Omicron work? – BBC
World is put on high alert over the Omicron coronavirus variant – CNN
Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant – Moderna
What’s known and unknown about Omicron, the coronavirus variant identified in South Africa – STAT
The new variant is worrying – but it doesn’t change how we tackle Covid – The Guardian
Omicron: everything you need to know about new Covid variant – The Guardian
Omicron variant unlikely to reboot Covid in UK, expert says – The Guardian
UK detects Omicron cases, as more countries eye new COVID-19 variant – CIDRAP
New COVID variant alarms researchers, triggers travel bans – CIDRAP
The omicron variant spreads across Europe as new travel bans take effect – NPR
What to know about omicron, the new COVID variant – NPR
What we know about the Omicron variant – CNN
The new Omicron variant is a pandemic gut check – CNN
What to know about the omicron variant of the coronavirus – The Washington Post
Commentary on Twitter (thread – click for more)
The Technical Advisory Group on SARS-CoV-2 Virus Evolution met today to review what is known about the #COVID19 variant B.1.1.529.
They advised WHO that it should be designated a Variant of Concern.
WHO has named it Omicron, in line with naming protocols https://t.co/bSbVas9yds pic.twitter.com/Gev1zIt1Ek— World Health Organization (WHO) (@WHO) November 26, 2021
Omicron Variant: Videos with opinions on the subject.
28 Nov, 2021 | 21:33h | UTC- Omicron: What we know so far about the new COVID-19 variant | DW News
- OMG Omicron? | A Doctor Explains, LIVE – ZDoggMD
Milestone Moment for Pandemic Treaty in Geneva – Calls for Tough Decisions by Countries.
28 Nov, 2021 | 21:28h | UTCSee also:
Countries prepare for pandemic treaty decision – The Lancet
WHO nears consensus on future international pact to prevent pandemics – diplomats – Reuters
The WHO is seeking a new treaty on handling future pandemics. It could be a hard sell – NPR
Commentary on Twitter
Pandemic treaty decision: "I think…there's enough support to begin negotiations over a legally binding agreement", @LawrenceGostin tells The Lancet.@jzarocostas reports from Geneva ahead of a Special Session of the World Health Assembly. https://t.co/rKdbPi8Bwo
— The Lancet (@TheLancet) November 27, 2021
Too early to tell, but preliminary information from doctors in South Africa suggests the new Covid variant Omicron may be associated with less severe disease.
28 Nov, 2021 | 21:35h | UTC- The Omicron Variant: What Matters Most Is… – by Dr David L. Katz
- New Covid Variant Omicron: South African medical association says Omicron variant causes ‘mild disease’ – Times of India
- Video: Omicron symptoms mild so far, says South African doctor who spotted it – BBC
- South African doctor who raised alarm about omicron variant says symptoms are ‘unusual but mild’ – The Telegraph
[Press release – not published yet] Merck’s new Covid-19 pill Molnupiravir updated data shows reduced efficacy (30%) for preventing hospitalization and death compared to initial results (50%). Absolute risk reduction of hospitalization and death fell from 7% to 3%.
28 Nov, 2021 | 21:30h | UTCCommentary: New data, analyses take some of the shine off Merck’s Covid pill – STAT
Related:
8 lingering questions about the new Covid pills from Merck and Pfizer.
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Commentaries on Twitter
Disappointing!!
?Merck Provides Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19
N=1433
RRR fell from 50% to 30%
Absolute Risk reduction only 3% #IDTwitter https://t.co/aX2b3xrdnB pic.twitter.com/uXUSQRNWC7— Antibiotic Stewa®️x? Bassam Ghanem (@ABsteward) November 26, 2021
Disappointing from Merck. Updated data for efficacy of their Molnupiravir pill in full trial drops down to 30% from 50%, absolute reduction to 3 from 7 per 100 at interim analysis https://t.co/PyfIBnFNC7 pic.twitter.com/SBDL92aG5M
— Eric Topol (@EricTopol) November 26, 2021
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
28 Nov, 2021 | 21:22h | UTCExecutive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report
Full Guideline: Screening for Lung Cancer: CHEST Guideline and Expert Panel Report
News Release: CHEST releases expert guidelines for lung cancer screening – Elsevier
Related:
Commentary on Twitter
CHEST Guidelines and Expert Panel Report contains 16 evidence-based recommendations for the benefits, harms, and implementation of low-dose chest computed tomography (CT) screening. https://t.co/4mvjEOftQl #CHESTOnc #CHESTGuidelines #LungCancerAwarenessMonth pic.twitter.com/uyh9Pf0s5s
— CHEST® Journal (@journal_CHEST) November 23, 2021
European countries mandate medical-grade masks over homemade cloth face coverings.
28 Nov, 2021 | 21:26h | UTCEuropean countries mandate medical-grade masks over homemade cloth face coverings – CNN
Randomized Trial: Conventional in vitro fertilization resulted in a cumulative live-birth rate that was noninferior to live-birth rates with the addition of preimplantation genetic testing for aneuploidy.
28 Nov, 2021 | 21:14h | UTCLive Birth with or without Preimplantation Genetic Testing for Aneuploidy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: New research casts fresh doubt on a common procedure that promises to increase the odds of IVF – STAT
ATS Guideline: Use of fractional exhaled nitric oxide to guide the treatment of asthma.
28 Nov, 2021 | 21:20h | UTC
International Consensus Statement on the diagnosis, multidisciplinary management, and lifelong care of individuals with achondroplasia.
28 Nov, 2021 | 21:16h | UTCInternational Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Commentary on Twitter
New content online: International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia https://t.co/sP3BbFsc5z pic.twitter.com/fR23dID0Hw
— Nature Reviews Endocrinology (@NatureRevEndo) November 26, 2021
ESSM Position Statement on Surgical Treatment of Peyronie’s Disease.
28 Nov, 2021 | 21:19h | UTCESSM Position Statement on Surgical Treatment of Peyronie’s Disease – Sexual Medicine
Commentary on Twitter
Latest #ESSM #PositionStatement on Surgical Treatment of #PeyroniesDisease! The choice of treatment depends on: the stage of the disease, the presence of pain, severity and direction of the curvature, penile length and the quality of #erectilefunction ➡️ https://t.co/qqfIzqBXtc pic.twitter.com/DSCZW6FJjm
— European Society for Sexual Medicine (ESSM) (@essm_tweets) November 24, 2021
M-A: Association of Glucagon-like Peptide 1 Analogs and agonists administered for obesity with weight loss and adverse events.
28 Nov, 2021 | 21:09h | UTC
M-A: Psychiatric disorders in individuals born very preterm / very low-birth weight.
28 Nov, 2021 | 21:11h | UTC
Brief review: The clinician’s guide to p values, confidence intervals, and magnitude of effects.
28 Nov, 2021 | 21:06h | UTCThe clinician’s guide to p values, confidence intervals, and magnitude of effects – Eye (if the link is paywalled, try this one)
Related:
Bayesian interpretation of p values in clinical trials.
Scientists Rise Up Against Statistical Significance
.050 shades of grey in p-value cutoffs
What a nerdy debate about p-values shows about science — and how to fix it – VOX
Big names in statistics want to shake up much-maligned P value – Nature News
‘One-size-fits-all’ threshold for P values under fire – Nature News
Statisticians issue warning over misuse of P values – Nature News
Understanding common misconceptions about p-values – The 20% Statistician
Fatigue as the chief complaint: epidemiology, causes, diagnosis, and treatment.
28 Nov, 2021 | 21:05h | UTC
Review: Studies for the evaluation of diagnostic tests.
28 Nov, 2021 | 20:59h | UTCStudies for the Evaluation of Diagnostic Tests – Deutsches Ärzteblatt International
Extravasation injuries of the limbs in neonates and children: development of a treatment algorithm.
28 Nov, 2021 | 21:03h | UTC
The musculoskeletal manifestations of Marfan Syndrome: diagnosis, impact, and management.
28 Nov, 2021 | 20:58h | UTC